Pharmacogenomics and Personalized Medicine
作者： Jing Li , Martin H. Bluth , Andrea Ferreira-Gonzalez
DOI: 10.1016/B978-1-4377-0974-2.00072-5
关键词: Medical physics 、 Personalized medicine 、 Pharmacogenomics 、 Medicine
摘要:
sci-hub.st 参考文章(295)
M Wasif Saif, Manasi Shah, K-ras mutations in colorectal cancer: a practice changing discovery. Clinical advances in hematology & oncology. ,vol. 7, pp. 45- 64 ,(2009)
Ewan, R Pearson, Pharmacogenetics and future strategies in treating hyperglycaemia in diabetes Frontiers in Bioscience. ,vol. Volume, pp. 4348- 4362 ,(2009) , 10.2741/3532
Christine L.H. Snozek, Dennis J. O'Kane, Alicia Algeciras-Schimnich, Pharmacogenetics of Solid Tumors: Directed Therapy in Breast, Lung, and Colorectal Cancer The Journal of Molecular Diagnostics. ,vol. 11, pp. 381- 389 ,(2009) , 10.2353/JMOLDX.2009.090003
Tatsuo Ohira, Norihiko Ikeda, Seisuke Nagase, Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers. Annals of Thoracic and Cardiovascular Surgery. ,vol. 15, pp. 144- 149 ,(2009)
Tsao-Wei D, Stoehlmacher J, Groshen S, Lenz Hj, Iobal S, Ghaderi, Park D, A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Research. ,vol. 21, pp. 3075- 3079 ,(2001)
Werner Kalow, Pharmacogenomics: Historical Perspective and Current Status Pharmacogenomics. ,vol. 311, pp. 003- 016 ,(2005) , 10.1385/1-59259-957-5:003
Wei Peng Yong, Federico Innocenti, Translation of pharmacogenetic knowledge into cancer therapeutics. Clinical advances in hematology & oncology. ,vol. 5, pp. 698- 706 ,(2007)
Guido Barbujani, Antti Sajantila, Oscar Lao, Jukka Corander, Johanna Sistonen, Silvia Fuselli, CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenetics and Genomics. ,vol. 17, pp. 93- 101 ,(2007) , 10.1097/01.FPC.0000239974.69464.F2
Jill Kolesar, Cindy Gaston, Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer. Clinical advances in hematology & oncology. ,vol. 6, pp. 825- 833 ,(2008)
Laurent P. Rivory, Marc Vuilhorgne, Alain Commerçon, Susan M. Pond, Jacques Robert, Marie-Christine Haaz, Jean-François Riou, Serge Sable, Identification and Properties of a Major Plasma Metabolite of Irinotecan (CPT-11) Isolated from the Plasma of Patients Cancer Research. ,vol. 56, pp. 3689- 3694 ,(1996)